Full Text View
Tabular View
No Study Results Posted
Related Studies
Acitretin Plasma Levels Under Hemodialysis
This study is currently recruiting participants.
Study NCT00488384   Information provided by University of Zurich
First Received: June 19, 2007   Last Updated: June 5, 2008   History of Changes

June 19, 2007
June 5, 2008
June 2007
December 2010   (final data collection date for primary outcome measure)
Plasma levels acitretin [ Time Frame: 2009 ] [ Designated as safety issue: No ]
Plasma levels acitretin [ Time Frame: 2009 ]
Complete list of historical versions of study NCT00488384 on ClinicalTrials.gov Archive Site
 
 
 
Acitretin Plasma Levels Under Hemodialysis
Acitretin Plasma Levels Under Hemodialysis

Acitretin is given to hemodialysis patients who have developed in-situ or invasive squamous cell carcinoma of the skin in increasing doses up to 25 mg daily for one year.

Acitretin is given to hemodialysis patients who have developed in-situ or invasive squamous cell carcinoma of the skin in increasing doses up to 25 mg daily for one year. Plasma levels of acitretin will be monitored and influence of hemodialysis on acitretin plasma levels will be determined. Number of in-situ or invasive squamous cell carcinoma of the skin cases will be determined.

  • Trial with medicinal product
Phase IV
Interventional
Prevention, Non-Randomized, Open Label, Historical Control, Single Group Assignment, Pharmacokinetics/Dynamics Study
Carcinoma, Squamous Cell
Drug: Chemopreventive application (Acitretin)
Other: single arm only.
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
2009
June 2011
December 2010   (final data collection date for primary outcome measure)

Inclusion criteria:

  • Hemodialyis patients with at least one case of in-situ or invasive squamous cell carcinoma of the skin

Exclusion criteria:

  • Hepatopathy
  • Pregnancy
Both
18 Years and older
Yes
Contact: 01 Studienregister MasterAdmins +41 (0)44 255 11 11
Switzerland
 
NCT00488384
hofbauer, university hospital zurich
2007DR2065 EK674
University of Zurich
 
Study Director: 01 Studienregister MasterAdmins UniversitaetsSpital Zuerich
University of Zurich
June 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP